Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -0.81% vs -0.92% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -47.84% vs 5.57% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -62.02% vs 36.61% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 33.06% vs -7.46% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Yifan Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -0.81% vs -0.92% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 5.02% vs 24.33% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -47.84% vs 5.57% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -20.15% vs 481.10% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -62.02% vs 36.61% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -29.14% vs 34.58% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 33.06% vs -7.46% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -14.06% vs 11.63% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






